Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 2, 2021

Aggregate testing results will be reported to the director of the summer camp via safeCircle’s integration with CLEARED4, the Company’s pooled surveillance testing program partner, through CLEARED4’s smartphone-based online health safety management and reporting solution. Testing will be conducted from mid-June through end-July.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Canna Law Blog

JANUARY 3, 2023

With the passage of the 2014 Farm Bill , CBD derived from hemp — if cultivated pursuant to a state research pilot program — got a little bit of precarious legal cover. It’s not like the FDA is unaware of the massive unregulated CBD market that already exists in the U.S.

CBD 75

CBD Food Clinical Trials Pets 75

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions. .

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

JANUARY 24, 2022

Accomplished leader to oversee Goldfinch Bio’s clinical function to advance precision medicines for people living with kidney disease. Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation is pending, House Bill 625, to establish an industrial hemp pilot program to be in compliance with the new federal hemp regulations. MS resident? Washington.

Legislation 158

Legislation Decriminalization Access Therapy 158

Cannabis Law Report

MARCH 29, 2022

Most recently Director of Compliance at the University of Pennsylvania’s Perelman School of Medicine, Dawn previously held senior Quality Assurance roles over the course of two decades at Merck. Dawn remains a faculty member at Penn directing the QA course of study for the ITMAT Masters program. Dawn Lundin, M.S. ,

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

MMJ Recs

DECEMBER 22, 2023

Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana. Local initiatives, workshops, and educational programs have been instrumental in disseminating accurate information about the benefits of medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Even though it cannot be used recreationally legally, in July of 2019, Ireland started a five-year pilot program to legalize medicinal cannabis.

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. In prior clinical trials conducted by Sesen Bio, EpCAM has been shown to be overexpressed in NMIBC cells with minimal to no EpCAM expression observed on normal bladder cells.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

DECEMBER 21, 2021

Prakat swiftly modernizes legacy business hardware, software programs, and downloadable apps. Facilitating workforce proof of health compliance data, Dalrada Health’s CLIA-certified laboratory provides on-site concierge services and holds national capability. billion in 2019 Q3. DALRADA ACHIEVES RECORD RESULTS.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JUNE 4, 2021

In 1996, California legalized medical cannabis yet today, with 37 US States allowing for medical cannabis sales, we still do not have an overall comprehensive cannabis/cannabinoid education program. We already see products with Delta 8-THC submitted at the state compliance level in California.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

NOVEMBER 12, 2021

Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. In compliance with current Good Manufacturing Practice requirements, the Company delivered ANEB-001’s active pharmaceutical ingredient to its contract manufacturer to fill into 10 mg and 50 mg capsules for finished product.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

SEPTEMBER 21, 2021

If we are going to provide medicinal cannabis opportunities covered by insurance, we need the ability to go through clinical trials and testing. Are your legislators and the OLCC working on programs to further improve the sector? . If we are going to be able to grow as businesses we need to work fluidly with regulators.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

JANUARY 9, 2019

Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment. It’s important to us to run local trials, so we are not relying on evidence from elsewhere,” Tindall said. “It It also gives us a fast-track program. It’s all about access and education,” said Tindall. “If

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 13, 2019

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. They are learning quickly from the successes and failures in Canada’s legal medical cannabis program that has been active since 2001. Arundati Dandapani. Founder and CEO, .

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

OCTOBER 17, 2019

Meanwhile, as of this writing, 33 US states have implemented some form of medical marijuana program. If the effort succeeds, the medical and recreational programs would likely operate side-by-side rather than combined, with each overseen by different government agencies and each taxed differently.

Law 40

Law Seed-To-Sale Hemp Recreational 40